deltatrials
Completed PHASE4 NCT02065076

Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients

Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Ambulatory Pre-dialysis Outpatients : a Randomized Triple-blind Placebo-controlled Trial

Sponsor: Maisonneuve-Rosemont Hospital

Conditions Chronic Kidney Failure Hyperkalemia
Interventions Lactose with carob gum Sodium polystyrene sulfonate
Updated 6 times since 2017 Last updated: Oct 1, 2014 Started: Feb 28, 2014 Primary completion: Sep 30, 2014 Completion: Oct 31, 2014

Listed as NCT02065076, this PHASE4 trial focuses on Chronic Kidney Failure and Hyperkalemia and remains completed. Sponsored by Maisonneuve-Rosemont Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Feb 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Feb 2023 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maisonneuve-Rosemont Hospital
  • Université de Montréal
Data source: Maisonneuve-Rosemont Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Montreal, Canada